Work

Cytopenia following axicabtagene ciloleucel (axi-cel) for refractory large B-cell lymphoma (LBCL).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.e14019

Authors: Jennifer Marilyn Logue, Gabriel S Krivenko, Victoria Larson, Christina A Bachmeier, Julio C. Chavez, Marco L. Davila, Farhad Khimani, Aleksandr Lazaryan, Hien D Liu, Javier Pinilla-Ibarz, Bijal D. Shah, Bhagirathbhai R. Dholaria, Michael D. Jain, Frederick Lundry Locke

Institutions: Moffitt Cancer Center, University of South Florida, Vanderbilt University, West Virginia University, Vanderbilt University Medical Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947312151

Cites:

Cited by: 3

Related to: 10